Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
1 clinical trials · Condition
◉ Watch Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
| Record | Firm | Date |
|---|---|---|
| REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) (NCT05973773) | Taiho Oncology, Inc. | 2023-12-18 |
Track Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation automatically
Every clearance here is in the API, with alerts when new ones post.